Guiding you through today’s uncertain and shifting environment
Understanding all possible market dynamics and adequately planning for each situation is a critical component to launching a product in today’s complex, disruptive and uncertain healthcare environment. At Baker Tilly, our commercial enablement team can help lead your life science organization through the myriad of situations that can cause a great deal of fear, uncertainty and doubt, including:
- Shifting to a new commercialization mindset: The line between traditional commercial execution and real world evidence is fading. From a shifting multi-customer environment with divergent demands for achieving economic outcomes and a movement from fee-for-service (FFS) to risk sharing cost models, disruptions across the life sciences industry are causing pharmaceutical and medical device companies to shift away from their traditional path to commercialization. This has caused companies to re-examine how they prepare for and execute their go-to-market strategies as well as the shift to a new commercialization mindset.
- Operational and regulatory dynamics: A shift in operational and regulatory dynamics is being primarily led by a multi-customer landscape possessing divergent demands for achieving economic outcomes, and a movement to value-based risk sharing arrangements. This is resulting in marketplace disruptions across all life science manufacturers that affect the growth path of all assets.
As a result, it has become even more imperative for your life science company to effectively plan for all possible contingencies and execute your go-to-market strategies with flexibility in order to adjust to ever-changing dynamics in today’s competitive marketplace.